medicine.jpg (3877 bytes) LSUMC.JPG (19761 bytes)
Allergy and Immunology
Comprehensive Medicine
Emergency Medicine
Infectious Disease
Physical Medicine and Rehablitation
Pulmonary/Critical Care


faculty.jpg (2610 bytes) interest.jpg (4449 bytes)


all_immu.jpg (5291 bytes)


Prem Kumar HLA-D Locus compatibility - Using early lymphocyte activation signals application in cadaveric renal transplantation.

Cost of care and quality of life of allergic rhinitis patient receiving allergen immuno therapy.

The influence of Yoga on asthma and on neuropeptides and cytokines.

Increased ocular pressure and cataracts following inhaled and nasal steroids for asthma and rhinitis.


Prakash N. Rao, Ph. D. Preservation and reperfusion injury; characterization

and implications for clinical transplantation.

CD-69 and urinary glutathione-S-transferases (GST)

as markers of immune injury in clinical renal transplantation.

Vitamin carrier protein in cancer; implications for early detection and treatment (with particular emphasis on breast, liver and prostate cancers).

DNA vaccines for the treatment of prostate and mannary carcinomas.

Evaluation of techniques of pyschoneuroimmunology (PNI) in the treatment of breast cancer.


cardio.jpg (3030 bytes)


J. Daniel Andress, M.D. Dr. Andress is the Assistant Director of the LSU Arrthymia Service Current research interests include drug studies and recent advances in defibrillator devices.


Thomas D. Giles, M.D. Dr. Giles is the Director of Cardiovascular Research. He is principal investigator for a number of clinical trials focused upon heart failure, hypertension, and angina. He has basic research interest in pathophysiologic mechanisms for development of heart failure in diabetes and hypertension.


Michael B. Givens, Ph.D. Dr. Given is a pharmacologist working in the field of diabetes and heart disease. He is currently investigating the effect of diabetes mellitus on bradykinin metabolism and its effect on the coronary circulation. He is also collaborating with other investigators on the role of the kinin system in the development of atherosclerosis in both normal and diabetic vessels.


D. Luke Glancy, M.D. Dr. Glancy is the Chief of the Section of Cardiology, Medical Director of Cardiology at the Medical Center of Louisiana in New Orleans and directs the interventional cardiology program. He also has special interest in scalar electrocardiography and congenital heart disease in adults. He directs several projects studying chemical aspects of cardiovascular disease.


Stanley S. Greenberg, Ph.D. Dr. Greenberg works in the Cardiovascular research laboratory. He runs the nitric oxide laboratory and has joint appointments in pharmacology and physiology, where he has student teaching responsibilities.


Frederick Helmcke, M.D. Dr. Helmcke is the Director of the LSU Echocardiography laboratory, implementing myocardial contrast Echocardiography and investigating 3 and 4 dimensional echocardiographic techniques. He’s also active in LSU’s Telemedicine Program.


Gary E. Sander, M.D., Ph.D. Dr. Sander functions as principal investigator for several clinical research studies and serves as editor for the Louisiana Chapter ACC Newsletter.


Akbar Shah, M.D. Dr. Shah is Associate Director of the LSU Cardiology Fellowship Program. Together with Dr. Glancey, he directs several clinical research projects.


Parakat Vijayagopal, Ph. D. Dr. Vijayagopal is primarily involved with cardiovascular research and his main interests are in the mechanisms of atherogenesis and in proteoglycan metabolism by vascular cells.


Summary of research interests: Cardiovascular research includes both basic and clinical science activities. The basic cardiovascular research interest include investigations into the pathogenesis of diabetic cardiovascular disease and atherosclerosis. Experiments models include animal and cellular preparations and extend from whole animal experiments to in vitro pharmacologic, biochemical and molecular investigations. Major clinical research areas of activity include congestive heart failure, hypertension and cardiomyopathies. Active clinical investigations include those concerned with pathophysiological and therapeutic aspects of heart disease, and include such disease processes as hypertension, heart failure, ischemic heart disease, and atrial fibrillation.


comp_med.jpg (5266 bytes)


No information at this time.


em_medic.jpg (4641 bytes)


James Moises, M.D. Currently  I am working with Nicolas Bazan at the Neuroscience Center studying traumatic brain injury and ischemic brain injury in a rat model.  We are looking at lipid second messengers, gene expression, and potential neuroprotective agents.   Clinically, I am open to any research project a student may be interested in conducting, with special interests in hypertension, chest pain diabetes, and sexually transmitted diseases in the Emergency Department setting.


endocrin.jpg (3827 bytes)


Chandan Prasad, Ph.D. Appetite regulation; Hormones and drug addiction; Neurobiology of aging; Diet, hormone and behavior program


Frank Svec, M.D., Ph.D. Appetite control in fat rats. Effect of DHEA on brain chemistry.


gastroen.jpg (4424 bytes)


Thiruven Ramakrishnan, M.D. H. Pylori: Effect of N-Acetylchystine on bacterial survival; H. pylori: Effect of Colony stimulating factor on infection; Pathogenesis of Barrett's Esophagus; colon polyps.


Nicholas Persich, M.D. Ascorbic acid and nitric oxide in Helicobacter pylori infection.


gen_geri.jpg (4790 bytes)


James C. Cohen, Ph.D. Molecular genetics of aging & cancer, use of the polymerase chain reaction to examine problems in infectious diseases


Henry Rothschild, M.D., Ph.D. Interaction of the environment with a gene in the cause of lung cancer; Loss of physiological function with age; Longevity genes in humans


hem_onco.jpg (5068 bytes)


Lowell B. Anthony, M.D. Anticancer therapies using radiolabelled somatostatin analogues


John N. Bickers, M.D. Investigational cancer treatment; Hospice care and pain control


Igor Espinoza-Delgado, M.D. Cancer immunotherapy; Apoptosis and cell cycle regulation


Chris Theodossiou, M.D. Use of clomiphene for metastatic breast cancer; use of anastrozole for Kaposi’s Sarcoma; use of liposomal antracyclines for prostate cancer; Clinical oncology protocols - SWOG


Richard H. Vial, M.D. Clinical oncology protocols - SWOG


Robert W. Veith, M.D. Stimulation of fetal hemoglobin, especially in sickle cell anemia


Donna A. Walker, M.D. Clinical oncology protocols - SWOG; Rural oncology care and supportive care



infect_d.jpg (3880 bytes)


Kenneth E. Aldridge Clinical & medical microbiology infections


Rebecca A. Clark, M.D. The epidemiology and therapy of HIV infections and opportunistic inflections in women


Julio E. Figueroa, II, M.D. The molecular biology of infectious causes of atherosclerosis including Chlamydia pneumoniae. The characterization and role of a new proteo glycan identified in the urine of patient’s with HIV wasting syndrome


Michael E. Hagensee, M.D., Ph.D. The Hagensee laboratory studies the human immune response against human papillomavirus.  Our laboratory is developing immune assyas to detect HPV-specific antibodies from serum or mucosal sites (cervix and saliva) as well as delineating the local immune factors from mucosal specimens.  In addition, our laboratory is developing novel PCR-based techniques to detect HPV DNA from cervical, urine, oral specimens, Pap smears, and pathologic tissue.  These techniques will be applied to various populations at high risk for HPV infection and disease namely adolescents, gay men with and without HIV infection and women with and without HIV infection.  Results from these studies will aid in current and future vaccine development efforts as well as in the current diagnosis of HPV infection.


David H. Martin, M.D. Molecular methods for studying the epidemiology of STD's and their diagnosis.  Pathogenesis of STD's in humans.


Stephanie N. Taylor, M.D. The epidemiology, detection and treatment of chlamydial and gonococcal infections in adolsecents based on large scale screening programs.


nephrolo.jpg (3091 bytes)


Effrain Reisin, M.D. The effect of obesity and weight reduction on hypertension and renal function; the effect of new antihypertensive medication ACE inhibitors and calcium channel blockers on hypertension and renal function.


J. David Wallin, M.D.

M. Eileen Cook, M.D.

Carolyn J. Pearce, M.D.

A large number of studies involving the study of the relationship between hypertension and renal diseases are being carried out in the renal section. Under the supervision of one of the investigators, an honor student will have the opportunity to recruit and follow patients in hypertension studies and learn and perform renal function studies.


nutritio.jpg (2440 bytes)


Barbara Y. Legardeur M.P.H, L.D. Dietary assessment; Diet and cancer; Nutrition education


Alfredo Lopez, M.D., Ph.D. Exercise and lipids; Nutrition and cancer; Vitamin A nutritional status; Steroids in obesity and heart disease; Lipo-proteins and coronary heart disease; cholesterol and gall stones.



physmed.jpg (7652 bytes)


Joseph J. Biundo, Jr., M.D. Rheumatoid arthritis treatment; Use of growth factors in diabetic foot ulcers; Use of erythropoietin to prevent transfusion related complications; Geriatric rehabilitation; Pain management; Musculoskeletal rehabilitation; The effect of Clinitron Bed on Transcutaneous Oxygen; Shoulder diseases; Potential use of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in the treatment of chronic con-healing diabetic foot ulcers.


Stephen Kishner, M.D. Shoulder problems in hemiplegia; Shoulder problems in quadriplegia; Neuropathy in Connective Tissue Disorders; Effect of temperature on Electromyography (EMG) Diagnosis of Carpal Tunnel Syndrome; Potential use of granulocyte macrophage colony stimulating factor (GM-CFS) in the treatment of pressure ulcers.


Robert C. Mipro, Jr., M.D. Stroke rehabilitation; Musculoskeletal rehabilitation; Geriatric rehabilitation; Diabetic foot care management; Functional independent measurement outcome in rehabilitation; Sports medicine rehabilitation


Mahmoud Sarmini, M.D. Potential use of granulocyte macrophage colony stimulating factor (GM-CSF) in the treatment of pressure ulcers; Revisiting diazepam use for spasticity in spinal cord injury


Furquan H. Siddiqui, M.D., ChB Use of platelet derived growth factors in diabetic foot and pressure ulcers; Use of Erythropoietin to prevent transfusion related complications; The effect of Clinitron Bed on Transcutaneous Oxygen; Functional independent measurement outcome in rehabilitation; Potential use of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in the treatment of chronic non-healing diabetic foot and pressure ulcers.


Rajesh Yadav, M.D. Use of platelet derived growth factors in diabetic foot ulcers; Stroke rehabilitation; Spinal cord injury rehabilitation; Traumatic brain injury rehabilitation; Use of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in the treatment of chronic non-healing diabetic foot ulcers.



pulmo_cc.jpg (5286 bytes)


Julie Brown, Ph.D. HIV tat effects on host defense, cellular proteins that interact with tat


Ben deBoisblanc, M.D. ARDS & pulmonary hypertension


Stephen Kantrow, M.D. Mitochondrial function during sepsis and during apoptosis


Jay K. Kolls, M.D. Gene therapy for lung, liver, and blood disorders using viral and non-viral vectors


Carol Mason, M.D. Alveolar macrophage dysfunction during sepsis; Sepsis-induced dysfunction of respiratory defense mechanisms, bacterial translocation and lung antibacterial defenses


Steve Nelson, M.D. Effect of alcohol on TNF and host defense; Cytokine-induced inflammatory lung disease; colony stimulating factors in pulmonary and systemic infection


Judd Shellito, M.D. Alveolar macrophage function during immunosuppression; Effect of alcohol on pulmonary host defenses, mechanism of resistance to PCP infection


Ann Weinacker, M.D. Neutrophil function in HIV infection


David A. Welsh, M.D. Lung injury and alveolar repair mechanisms including cell-cell and cell-extracellular matrix interations.  Active lung injury models include ventilator induced lung injury and tobacco-related lung injury.

Clinical research projects focus on HIV-associated lung disease including pneumonia diagnosis, transmission of Pneumocystis carinii and pulmonary compartmentalization of virus.


Ping Zhang, Ph.D. Effects of alcohol on host defense during infection and inflammation



rheumato.jpg (3428 bytes)


Luis R. Espinoza Dr. Espinoza's research interest deals with the study of fibroblast-derived cytokines, and growth factors in psoriatic arthritis, and search for bacterial antigens in synovium by PCR


Hugh McGrath, Jr. At the moment I am treating systemic lupus erythematosus patients with long wavelength ultraviolet light.  Although the shorter wavelengths exacerbate this disease, the longer wavelengths that in solar radiation are in balance with the shorter wavelengths ameliorate disease.  We have already established that low doses of this light reverses clinical activity and are now in the process of determining why.   Because fatigue, lack of concentration, and mood respond briskly, we are using PET scans to evaluate functional changes in the brain before and after therapy to account for the improvement in mentation, fatigue, and mood.  At the same time we are assessing levels of heme oxygenase and nitric oxide, as we have reasons to believe that these are key to the attenuation of rashes and joint pain that characterize the therapy.   Collaborating are Admasu Maru in Dr. Lancaster's lab and Jawed Alam, the Co-director of the Dept. of Molecular Genetics.  Admasu is doing the nitric oxide studies and Jawed is managing the heme oxygenase assays.  We would welcome help from any young investigator who is interested in lupus or in the fascinating actions of ultraviolet radiationn.


Eve Scopelitis Dr. Scopelitis is interested in osteoporosis, and in several clinical studies using newer anti-inflammatory drugs.


Wendell A. Wilson Genetic origins of antiphospholipid antibodies andsystemic lupus erythematosus. The role of complement deficiencies, particularly C4, in the pathogenesis of systemic lupus erythematosus, and primary antiphospholipid antibody syndrome, is the subject of Dr. Wilson's research interest.